skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study

Journal Article · · International Journal of Radiation Oncology, Biology and Physics
 [1];  [2];  [1];  [3];  [1]
  1. Department of Epidemiology, Netherlands Cancer Institute, Amsterdam (Netherlands)
  2. Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam (Netherlands)
  3. Department of Medical Oncology, Erasmus MC, Daniel den Hoed Cancer Center, Rotterdam (Netherlands)

Purpose: To assess long-term cause-specific mortality in breast cancer patients. Patients and Methods: We studied mortality in 7425 patients treated for early breast cancer between 1970 and 1986. Follow-up was 94% complete until January 2000. Treatment-specific mortality was evaluated by calculating standardized mortality ratios (SMRs) based on comparison with general population rates and by using Cox proportional hazards regression. Results: After a median follow-up of 13.8 years, 4160 deaths were observed, of which 76% were due to breast cancer. Second malignancies showed a slightly increased SMR of 1.2 (95% confidence interval [CI], 1.0-1.3). Radiotherapy (RT) as compared with surgery was associated with a 1.7-fold (95% CI, 1.2-2.5) increased mortality from cardiovascular disease (CVD). After postlumpectomy RT, no increased mortality from CVD was observed (hazard ratio, 1.0; 95% CI, 0.5-1.9). Postmastectomy RT administered before 1979 and between 1979 and 1986 was associated with a 2-fold (95% CI, 1.2-3.4) and 1.5-fold (95% CI, 0.9-2.7) increase, respectively. Patients treated before age 45 experienced a higher SMR (2.0) for both solid tumors (95% CI, 1.6-2.7) and CVD (95% CI, 1.3-3.1). Conclusion: Currently, a large population of breast cancer survivors is at increased risk of death from CVDs and second cancers, especially when treated with RT at a young age. Patients irradiated after 1979 experience low (postmastectomy RT) or no (postlumpectomy RT) excess mortality from CVD.

OSTI ID:
20793386
Journal Information:
International Journal of Radiation Oncology, Biology and Physics, Vol. 64, Issue 4; Other Information: DOI: 10.1016/j.ijrobp.2005.10.022; PII: S0360-3016(05)02945-7; Copyright (c) 2006 Elsevier Science B.V., Amsterdam, Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0360-3016
Country of Publication:
United States
Language:
English

Similar Records

Radioactive iodine therapy and breast cancer. A follow-up study of hyperthyroid women
Journal Article · Sun May 01 00:00:00 EDT 1988 · Am. J. Epidemiol.; (United States) · OSTI ID:20793386

Radioactive iodine therapy and breast cancer. A follow-up study of hyperthyroid women
Journal Article · Sun May 01 00:00:00 EDT 1988 · Am. J. Epidemiol.; (United States) · OSTI ID:20793386

Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors
Journal Article · Fri Apr 01 00:00:00 EDT 2016 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:20793386